Swiss industrial conglomerate Metall Zug reduced its first-half net loss to 4.40 million Swiss francs from a year-earlier deficit, citing a 5.5% organic increase in net sales to 95.60 million Swiss francs.
The group’s earnings before interest and taxes remained negative at 3.70 million Swiss francs, though its trading result reached break-even. Metall Zug attributed the improvement to structural changes and reduced research and development spending, particularly within its medical devices unit, which returned to profitability.
Growth in the medical devices division was driven by higher unit volumes in its core slit lamp business. The company noted that currency pressures, primarily from the weak U.S. dollar, weighed on reported sales and competitiveness during the period.
Metall Zug flagged high volatility and limited visibility for the remainder of 2026, cautioning that forecasting remains challenging. Despite near-term uncertainty, the group expressed confidence in the medium- and long-term prospects of its business units.
